Talus Bioscience Analysis: $11M Raised
What is Talus Bioscience?
Talus Bioscience develops drugs targeting "undruggable" transcription factors to treat cancer and diabetes using functional proteomics and machine learning.
Employees
16
Founded
2020
Revenue
$1-5M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
- MARMOT platform for targeting transcription factors, functional proteomics, automated biology, machine learning for drug development, focus on hard-to-treat transcription factor proteins.
How much Talus Bioscience raised
1 - $11.2 million
August 20, 2024Lead Investor: Two Bear Capital
Who are the founders of Talus Bioscience
AF
Alex Federation
Founder
LP
Lindsay Pino
CTO
Investors
- Two Bear Capital
- WRF Capital
- NFX
- YC Continuity Fund
- Funders Club VC
- BoxOne Ventures
